Factors Related to the Willingness of Young Gay Men to Participate in Preventive HIV Vaccine Trials
- 1 February 1999
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 20 (2) , 164-171
- https://doi.org/10.1097/00042560-199902010-00009
Abstract
Given their high seroincidence, young gay men will be targeted for recruitment into HIV vaccine trials but many challenges stand in the way of enlisting their cooperation. This study examined factors associated with young gay men's willingness to participate in vaccine trials and identified reasons for agreeing or not agreeing to participate. The data come from the Young Men's Survey, a cohort of western U.S. young gay men aged 18 to 29 years, surveyed using mail-back questionnaires. Participants who reported being HIV-negative or who had not been tested for HIV (n = 390) were asked to rate their desire to be given an HIV vaccine and their degree of willingness to participate in a vaccine trial. They also responded to openended questions regarding their reasons for participating or not participating. Of these respondents, 91% wanted to be given an HIV vaccine, yet many had serious reservations about participating in a vaccine trial. Men who had engaged in HIV risk behavior reported greater willingness to participate. The most common reasons for wanting to participate were desires to contribute to ending the AIDS epidemic and desire to help others: however, fears for one's own health and safety made many reluctant to participate.Keywords
This publication has 11 references indexed in Scilit:
- Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United StatesAIDS, 1998
- Feasibility of Human Immunodeficiency Virus Vaccine Trials in Homosexual Men in the United States: Risk Behavior, Seroincidence, and Willingness to ParticipateThe Journal of Infectious Diseases, 1996
- Interest among Gay/Bisexual Men in Greater Boston in Participating in Clinical Trials of Preventive HIV VaccinesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Phase I/II Preventive Vaccine Trials: Conference SummaryAIDS Research and Human Retroviruses, 1995
- Progress Toward Readiness for Efficacy Trials in the United States: Conference SummaryAIDS Research and Human Retroviruses, 1995
- EditorialJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study.American Journal of Public Health, 1994
- HIV vaccine trials: will intravenous drug users enroll?American Journal of Public Health, 1994
- Reduced Virus Load in Rhesus Macaques Immunized with Recombinant gp160 and Challenged with Simian Immunodeficiency VirusAIDS Research and Human Retroviruses, 1994
- Scientific and Social Issues of Human Immunodeficiency Virus Vaccine DevelopmentScience, 1993